Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Limb discomfort, Pain in extremity, Pulmonary thrombosis, Thrombosis
Clinical narrative: Still having breathing issues as a result of the lung blood clot; Trouble with leg; Sore arm; Blood clot in his leg/Another blood clot developed on his right lung; Blood clot developed on his right lung; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (Blood clot in his leg/Another blood clot developed on his right lung), PULMONARY THROMBOSIS (Blood clot developed on his right lung), DYSPNOEA (Still having breathing issues as a result of the lung blood clot), LIMB DISCOMFORT (Trouble with leg) and PAIN IN EXTREMITY (Sore arm) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2021, the patient experienced THROMBOSIS (Blood clot in his leg/Another blood clot developed on his right lung) (seriousness criteria hospitalization and medically significant) and PULMONARY THROMBOSIS (Blood clot developed on his right lung) (seriousness criteria hospitalization and medically significant). On an unknown date, the patient experienced DYSPNOEA (Still having breathing issues as a result of the lung blood clot) (seriousness criterion hospitalization), LIMB DISCOMFORT (Trouble with leg) (seriousness criterion hospitalization) and PAIN IN EXTREMITY (Sore arm) (seriousness criterion hospitalization). At the time of the report, THROMBOSIS (Blood clot in his leg/Another blood clot developed on his right lung), DYSPNOEA (Still having breathing issues as a result of the lung blood clot) and LIMB DISCOMFORT (Trouble with leg) had not resolved and PULMONARY THROMBOSIS (Blood clot developed on his right lung) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment medication included a blood thinner.  Company Comment: This case concerns a 51-year-old, male patient with no relevant medical history, who experienced the unexpected serious event of Pulmonary thrombosis, thrombosis, dyspnoea, limb discomfort and pain in extremity. The events occurred on an unknown day after the first dose of Spikevax. The rechallenge was unknown since there is no information about the second dose. The benefit-risk relationship of Spikevax is not affected by this report.; Sender's Comments: This case concerns a 51-year-old, male patient with no relevant medical history, who experienced the unexpected serious event of Pulmonary thrombosis, thrombosis, dyspnoea, limb discomfort and pain in extremity. The events occurred on an unknown day after the first dose of Spikevax. The rechallenge was unknown since there is no information about the second dose. The benefit-risk relationship of Spikevax is not affected by this report.